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Abstract
Three-component coupling of the lithium enolate of t-BuOAc, silyl glyoxylate, and an α,β-
unsaturated ketone enables the rapid construction of the trachyspic acid carbon skeleton. A 3,4-
disubstituted isoxazole is utilized to mask the C7/C9 dicarbonyl. New enolsilane/nitrile-oxide
cycloadditions enable the preparation of various 3,4-disubstituted isoxazoles that are challenging
to access by other means.
Trachyspic acid (1) was isolated from the culture broth of Talaromyces trachyspermus
SANK 12191.1 Trachyspic acid possesses a substituted citric acid subunit and a hydrophobic
sidechain, defining characteristics of the 2-alkyl citrate natural products, and as an inhibitor
of tumor heparanase (IC50 = 36 μM), it has inspired several synthetic studies.2–6 The
contiguous C3 and C4 chiral centers and the efficient management of the unusual C6–C9
β,γ-diketoaldehyde have proven to be the principle hurdles to synthesis. For construction of
the former subunit, previous syntheses of trachyspic acid have employed either aldol2,3,6 or
Ireland-Claisen rearrangement4,5 strategies. The occurrence of the fully substituted C3
glycolic acid suggested the opportunity to develop a new silyl glyoxylate-based three-
component coupling7–13 that might permit efficient access to the core substructure. This
Letter details experiments directed to this end.
The open chain form (2) of trachyspic acid reveals a 1,4-relationship between the C3
glycolic acid and the C6 ketone, hinting at a potential Michael addition of a silyl glyoxylate
with an appropriately functionalized α,β-unsaturated ketone (Scheme 1); however, a C6/C7/
C9 tricarbonyl compound would pose an intractable chemoselectivity challenge in the
projected three-component coupling. In the interest of streamlining fragment assembly and
minimizing functional group and protecting group manipulations,14 masking the C7/C9-
dicarbonyl as an isoxazole emerged as an attractive possibility.15 This particular packaging
of reactive functionality was expected to present the C4 enone as the most electrophilic site
on compound 5 and permit downstream unmasking of the C7/C9 keto aldehyde via N–O
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hydrogenolysis and hydrolysis. The ideal nucleophilic component for the proposed coupling
would be an acetate enolate and the needed three-component coupling would in principle
complete the full trachyspic acid carbon skeleton.
Preliminary studies focused on the synthesis of Michael acceptor 5. Nitrile-oxide
cycloaddition with alkynes represents a direct and reliable route to isoxazoles; however,
steric effects dictate that terminal alkynes always provide 3,5-disubstituted isoxazoles 9, the
incorrect regioisomer needed for the application at hand (Scheme 2).16 Examples of the
preparation of 3,4-disubstituted isoxazoles by nitrile-oxide cycloaddition are scarce.17 The
majority of these approaches rely on a tethered nitrile-oxide18 or a vinylogous amide or ester
directing group.19
We sought to dictate the regiochemistry of nitrile-oxide cycloaddition electronically using
an electron-rich olefin dipolarophile. For the nitrile-oxide component we selected
carboethoxyformonitrile oxide (CEFNO), due to its facile in situ preparation from stable
ethyl chlorooximidoacetate (8) (Scheme 2). While nitrile-oxide precursor 8 is commercially
available, it can also be prepared in one step from ethyl glycine.20 Initial experiments
utilized enol acetate and alkyl enol ether dipolarophiles, which provided the undesired
furoxan dimer 11 as the major product. We hypothesized that employing a more electron-
rich dipolarophile would facilitate cycloaddition with the electron-poor nitrile-oxide; thus,
enolsilanes were tested. Syringe pump addition of triethylamine over 15 h to a solution of
oxime 8 and an enolsilane, followed by addition of TsOH˙H2O and warming to reflux,
resulted in the regioselective formation of a 3,4-disubstituted isoxazole.
Since the preparation of 3,4-disubstituted isoxazoles is an unsolved problem in organic
synthesis, we evaluated the broader applicability this cycloaddition. Various aldehyde- and
ketone-derived enolsilanes were effective dipolarophiles, including both linear and branched
alkyl variants (Scheme 3). The regioselective synthesis of isoxazole 10f (from the enolsilane
of 3-pentanone) was serviceable where 2-pentyne/CEFNO cycloaddition was not (<10%
yield; ~1:1 mixture of constitutional isomers). The preparation of fused-ring isoxazoles is
another challenge to organic chemists that was addressed by this method. Small and medium
cycloalkynes are unstable due to ring strain, so the preparation of fused-ring isoxazoles has
inspired creative methods.21,22 Five-, six-, and seven-membered ring enolsilanes were found
to be competent in the cycloaddition (10g–10j). The modest yields are believed to be due to
a combination of product volatility and ester hydrolysis (during the aromatization step). The
enolsilanes were used without prior distillation allowing for the operationally simple
preparation of isoxazoles in two steps from carbonyl compounds. Prior purification of the
enolsilanes did not improve the yields of isoxazole products.
Having developed a reliable, scalable (6.4 g) method for the preparation of isoxazole 10a,
we next pursued the completion of enone 5. Claisen condensation with lithiated methyl
dimethyl phosphonate provided β-ketophosphonate 12 (Scheme 4). t-Butyl glyoxylate
underwent olefination (LiCl/Et3N), but downstream operations were problematic with this
substrate. Thus, the 2-furyl group was selected to mask the C4 carboxylic acid. Olefination
of 2-furfural proceeded smoothly with aqueous K2CO3 at 100 °C to afford the desired enone
13 (>20:1 E:Z).
Studies commenced on the heretofore unknown three-component glycolate Michael
reaction. Based on prior studies in our group,9,11 initial experiments employed Reformatsky
reagents as nucleophilic triggers; however, unselective mixtures of three-component aldol
and Michael addition to the enone 13 were found to be the major products. In contrast, use
of lithium enolate 14 provided the Michael addition product 15 (Scheme 5), with no trace of
undesired 1,2-addition. Solvent choice influenced the diastereoselectivity: THF provided
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2.7:1 dr favoring the desired isomer, while the diastereoselectivity was inverted when
toluene (1:1.7), hexanes (1:1.5), or diethyl ether (1:2.0) were utilized. The ability to switch
the diastereoselectivity by changing solvents could be an asset for analogue synthesis. This
coupling generates two C–C bonds, the critical C3 and C4 stereogenic centers, and
completes the full carbon skeleton of trachyspic acid. A reaction conducted with 3.7 g of
enone 13 provided 4.9 g of diastereomerically pure 15.
With ketone 15 in hand, remaining synthetic operations included isoxazole N–O cleavage,
furan oxidation, and spiroketalization. Exposing ketone 15 to either oxidative or reductive
conditions was ineffective at cleaving the furan or the isoxazole, respectively.
Decomposition of 15 during isoxazole reduction attempts was believed to be a consequence
of the reactivity of the C6 ketone. Treating ketone 15 with acidic methanol resulted in
transesterification and mixed methyl ketal formation. Ketal 16 underwent successful N–O
reduction with Mo(CO)6 to provide enamine 17 (Scheme 6).23 With the C7–C9 dicarbonyl
equivalent unmasked, the stage was set for formation of the 5,5-spiroketal.
We expected that Brønsted acid-promoted ketalization of 17 would furnish C6 spiroketal 18.
Following the model of Rizzacasa5 and Hatakeyama,6 enamine 17 was treated with 3 M
HClO4; however, rather than the expected spiroketal 18, ketone 22 was generated as the
major product (Scheme 7). Ketone 22 is presumably formed by enamine hydrolysis and
retro-Claisen fragmentation of the C8–C9 bond. Other aqueous Brønsted acids were also
found to trigger the same undesired fragmentation.
In an effort to avoid retro-Claisen fragmentation, we tested a series of less nucleophilic
ketalization conditions. A number of Lewis acids were found to induce only tautomerization
or no reaction, but TiCl4 demonstrated unique efficacy in promoting spiroketalization.
Quenching the reaction with 1 M HCl resulted in hydrolysis of the imine intermediate and
hydration of the intermediate C9 enol ether to provide spiroketal 18 as a mixture of
diastereomers (Scheme 6). Multiple repetitions of the synthetic sequence revealed sporadic
diastereoselectivity in the spiroketalization, which ranged from as high as 5:1 dr to as low as
1.5:1 dr The major diastereomer was found to correspond to the natural isomer in each case.
Oxidative furan deprotection furnished acid 19, revealing the citric acid motif (Scheme 6).
Subsequent hemiacetal dehydration delivered trachyspic acid dimethyl ester 20. Methylation
of the lone carboxylic acid gave the known trachyspic acid trimethyl ester 21, as confirmed
by 1H NMR and 13C NMR analysis.1 Compounds 20 and 21 have proven to be
unexpectedly recalcitrant toward numerous conventional and unconventional saponification
conditions.
In summary, the trachyspic acid dimethyl ester was prepared in 10 linear steps from
commercially available undecanal. Key steps include a silyl glyoxylate three-component
coupling, as well as a new nitrile-oxide cycloaddition of an enolsilane dipolarophile. The
latter enables the synthesis of various 3,4-disubstituted isoxazoles that are challenging to
access by other means. The aim of future work is to evaluate the scope of the glycolate
Michael reaction in the context of other alkyl citrate natural products.
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Retrosynthetic analysis of trachyspic acid.
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Regioselectivity of Nitrile-Oxide Cycloaddition
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Enolsilane Dipolarophiles in Nitrile-Oxide Cycloaddition
Yields are of isolated material after column chromatography, average of at least two trials.
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Synthesis of the C4–C9 Enone
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Progress Toward Trachyspic Acid
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